Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    3131406 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis
Conditions: Asthma;   Allergic Rhinitis
Interventions: Drug: Fluticasone Evohaler pMDI;   Drug: Placebo;   Drug: Fluticasone Evohaler;   Drug: Placebo intranasal spray;   Drug: fluticasone propionate (Flixonase®)

Indicates status has not been verified in more than two years